EST. 2026

FlowSense Story

FlowSense Medical emerged from the intersection of clinical necessity and innovative engineering. Our mission is clear: to eliminate IV push medication errors that impact millions of patients globally. By harnessing advanced sensing technology, we provide clinicians with the real-time data they need to ensure every bolus is delivered with absolute precision and safety.

Executive Leadership

Our Team

Two colleagues in blue scrubs celebrating with balloons

FlowSense Medical was founded by Co-Founders Joseph P. Monroe III and Gabrielle L. Redmond to close the gap between frontline clinical reality and advanced sensing technology. Together, they are building tools that make IV push dosing safer, more transparent, and easier to manage at the bedside—so patients, clinicians, and health systems all see better outcomes.

Joseph P. Monroe III, Co-Founder
Gabrielle L. Redmond, Co-Founder

Gabrielle Redmond and Joseph Monroe are the co-founders of FlowSense Medical, a healthcare innovation company focused on improving patient safety and clinical precision. Combining backgrounds in nursing, emergency medicine, and patient care, they developed PushSense—a smart syringe accessory designed to provide real-time feedback on IV push medication administration. Their work is driven by a shared commitment to reducing preventable medication errors and advancing safer standards in clinical practice.

VISION • SCALE • IMPACT • VISION • SCALE • IMPACT

The Global Standard in IV Safety

FlowSense Medical is redefining the landscape of injectable medication. By bridging the gap between clinical estimation and digital precision, we are building a future where every IV push is monitored, validated, and optimized for patient safety.

Clinical Engagement

Direct Channels for Strategic Partnership

We bridge laboratory discovery and market-ready clinical solutions. Our investor relations team is available for inquiries regarding our patent pending sensing IP and scalable biotech assets.